Aptargroup, Inc. ATR
We take great care to ensure that the data presented and summarized in this overview for APTARGROUP, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ATR
View all-
Vanguard Group Inc Valley Forge, PA7.16MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.16MShares$1.04 Billion0.02% of portfolio
-
Morgan Stanley New York, NY4.93MShares$834 Million0.05% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL4.74MShares$802 Million0.6% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA2.88MShares$488 Million1.22% of portfolio
-
State Street Corp Boston, MA2.88MShares$486 Million0.02% of portfolio
-
Victory Capital Management Inc1.63MShares$275 Million0.24% of portfolio
-
Boston Trust Walden Corp1.45MShares$245 Million1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA1.43MShares$242 Million0.02% of portfolio
-
Neuberger Berman Group LLC New York, NY1.29MShares$218 Million0.15% of portfolio
Latest Institutional Activity in ATR
Top Purchases
Top Sells
About ATR
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Insider Transactions at ATR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 28
2024
|
Stephan B. Tanda President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-5.06%
|
$5,100,000
$170.16 P/Share
|
Oct 28
2024
|
Stephan B. Tanda President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.81%
|
$2,220,000
$74.79 P/Share
|
Sep 13
2024
|
Hedi Tlili Segment President |
SELL
Open market or private sale
|
Direct |
1,375
-12.79%
|
$209,000
$152.54 P/Share
|
Sep 09
2024
|
Gael Touya Segment President |
SELL
Open market or private sale
|
Direct |
3,300
-9.3%
|
$498,300
$151.62 P/Share
|
Aug 29
2024
|
Marc Prieur Segment President |
SELL
Open market or private sale
|
Direct |
3,500
-17.4%
|
$532,000
$152.31 P/Share
|
Aug 29
2024
|
Marc Prieur Segment President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+14.82%
|
$248,500
$71.12 P/Share
|
Aug 26
2024
|
Shiela Vinczeller Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,660
-6.83%
|
$250,660
$151.15 P/Share
|
Aug 26
2024
|
Robert Kuhn EVP & CFO |
SELL
Open market or private sale
|
Direct |
1,000
-1.5%
|
$151,000
$151.29 P/Share
|
Aug 26
2024
|
Robert Kuhn EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.48%
|
$64,000
$64.6 P/Share
|
Aug 23
2024
|
Robert Kuhn EVP & CFO |
SELL
Open market or private sale
|
Direct |
49,463
-21.54%
|
$7,419,450
$150.25 P/Share
|
Aug 23
2024
|
Robert Kuhn EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,463
+30.07%
|
$3,165,632
$64.6 P/Share
|
Aug 22
2024
|
Robert Kuhn EVP & CFO |
SELL
Open market or private sale
|
Direct |
200
-0.3%
|
$30,000
$150.18 P/Share
|
Aug 22
2024
|
Robert Kuhn EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.3%
|
$12,800
$64.6 P/Share
|
Aug 15
2024
|
Xiangwei Gong President, Asia |
SELL
Open market or private sale
|
Direct |
7,200
-35.69%
|
$1,051,200
$146.52 P/Share
|
Aug 13
2024
|
Monnas Giovanna Kampouri Director |
SELL
Open market or private sale
|
Direct |
1,922
-17.86%
|
$276,768
$144.43 P/Share
|
Aug 07
2024
|
Xiangwei Gong President, Asia |
SELL
Open market or private sale
|
Direct |
800
-3.81%
|
$116,800
$146.56 P/Share
|
Aug 01
2024
|
Daniel Ackerman Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,264
+16.52%
|
-
|
Jul 29
2024
|
Stephan B. Tanda President and CEO |
SELL
Open market or private sale
|
Direct |
32,000
-5.45%
|
$4,704,000
$147.48 P/Share
|
Jul 29
2024
|
Stephan B. Tanda President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+13.44%
|
$2,368,000
$74.79 P/Share
|
Jun 06
2024
|
Kimberly Chainey EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
825
-8.56%
|
$120,450
$146.77 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 96.6K shares |
---|---|
Exercise of conversion of derivative security | 151K shares |
Payment of exercise price or tax liability | 39.5K shares |
---|---|
Open market or private sale | 184K shares |